These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 9253711)

  • 1. Gene-based strategies for the immunotherapy of cancer.
    Tüting T; Storkus WJ; Lotze MT
    J Mol Med (Berl); 1997 Jul; 75(7):478-91. PubMed ID: 9253711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy.
    Tiptiri-Kourpeti A; Spyridopoulou K; Pappa A; Chlichlia K
    Pharmacol Ther; 2016 Sep; 165():32-49. PubMed ID: 27235391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer immunotherapy in clinical oncology.
    Knuth A; Jäger D; Jäger E
    Cancer Chemother Pharmacol; 2000; 46 Suppl():S46-51. PubMed ID: 10950148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine-mediated gene therapy for cancer.
    Miller AR; McBride WH; Hunt K; Economou JS
    Ann Surg Oncol; 1994 Sep; 1(5):436-50. PubMed ID: 7850546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunodominance across HLA polymorphism: implications for cancer immunotherapy.
    Kim CJ; Parkinson DR; Marincola F
    J Immunother; 1998 Jan; 21(1):1-16. PubMed ID: 9456431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic immunotherapy for cancer.
    Ribas A; Butterfield LH; Economou JS
    Oncologist; 2000; 5(2):87-98. PubMed ID: 10794799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA vaccine for cancer immunotherapy.
    Yang B; Jeang J; Yang A; Wu TC; Hung CF
    Hum Vaccin Immunother; 2014; 10(11):3153-64. PubMed ID: 25625927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modifying adenoviral vectors for use as gene-based cancer vaccines.
    Basak SK; Kiertscher SM; Harui A; Roth MD
    Viral Immunol; 2004; 17(2):182-96. PubMed ID: 15279698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetically modified tumour vaccines--where we are today.
    Nawrocki S; Mackiewicz A
    Cancer Treat Rev; 1999 Feb; 25(1):29-46. PubMed ID: 10212588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lentiviral vectors for anti-tumor immunotherapy.
    Breckpot K; Emeagi PU; Thielemans K
    Curr Gene Ther; 2008 Dec; 8(6):438-48. PubMed ID: 19075627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient Uptake of Recombinant Lipidated Survivin by Antigen-Presenting Cells Initiates Antigen Cross-Presentation and Antitumor Immunity.
    Chiang CY; Chen YJ; Wu CC; Liu SJ; Leng CH; Chen HW
    Front Immunol; 2018; 9():822. PubMed ID: 29755461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responses.
    Feder-Mengus C; Schultz-Thater E; Oertli D; Marti WR; Heberer M; Spagnoli GC; Zajac P
    Hum Gene Ther; 2005 Mar; 16(3):348-60. PubMed ID: 15812230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor vaccination: where we stand.
    Bocchia M; Bronte V; Colombo MP; De Vincentiis A; Di Nicola M; Forni G; Lanata L; Lemoli RM; Massaia M; Rondelli D; Zanon P; Tura S
    Haematologica; 2000 Nov; 85(11):1172-206. PubMed ID: 11074658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic approaches for biologic therapy of cancer.
    Gambotto A; Cicinnati V; Robbins PD
    Drugs Today (Barc); 2000 Jan; 36(1):25-39. PubMed ID: 12879102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetically modified dendritic cells in cancer therapy: implications for transfusion medicine.
    Foley R; Tozer R; Wan Y
    Transfus Med Rev; 2001 Oct; 15(4):292-304. PubMed ID: 11668436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine gene transfer into dendritic cells for cancer treatment.
    Tirapu I; Rodriguez-Calvillo M; Qian C; Duarte M; Smerdou C; Palencia B; Mazzolini G; Prieto J; Melero I
    Curr Gene Ther; 2002 Feb; 2(1):79-89. PubMed ID: 12108975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunotherapy: new insights].
    Geissler M; Weth R
    Praxis (Bern 1994); 2002 Dec; 91(51-52):2236-46. PubMed ID: 12564040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cell vaccines for cancer immunotherapy.
    Timmerman JM; Levy R
    Annu Rev Med; 1999; 50():507-29. PubMed ID: 10073291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral vectors in cancer immunotherapy: which vector for which strategy?
    Collins SA; Guinn BA; Harrison PT; Scallan MF; O'Sullivan GC; Tangney M
    Curr Gene Ther; 2008 Apr; 8(2):66-78. PubMed ID: 18393828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applications of gene transfer to cellular immunotherapy.
    Terando A; Chang AE
    Surg Oncol Clin N Am; 2002 Jul; 11(3):621-43. PubMed ID: 12487059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.